YHK-803

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameYHK-803
Drug Alias NameYHK-803
ClassificationBiologics
Mechanisms of ActionmicroRNA-22 modulators
TargetsmicroRNA-22
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Yunhai Tetrahedron Biotechnology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Academy Of Medical Sciences &Sichuan Provincial People’S Hospital
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A